Ticking viral bombs, left in boxes | Pakistanis use fake polio vaccination cards to travel overseas | Experts call for risk-benefit talks on lab-modified pathogens | The science of disarming Syria’s chemical weapons | Ebola outbreak update and current case count | Identifying monoclonal antibodies that potently inhibit MERS-CoV | Poor oversight catches up with high-security infectious agent labs | There is no such thing as Ebola | Cape Ray continues neutralizing Syrian chemical materials | The virus detective who discovered Ebola in 1976 | Want a grant? First review someone else’s proposal | CDC director admits to pattern of unsafe practices | U.S. recovers hundreds of misplaced pathogen containers | Spread of chikungunya: A greater risk of spillover in Europe? | NSABB chief says board’s idling due to slow fed policy work | Sanofi’s 1.5B dengue vaccine shows Phase III promise, but questions linger | 20th CBRNE integrates into decisive action training | Foot and mouth disease international field trials workshop | Emergency readiness of health-care providers | Congress asks why CDC safety problems persist
See what we’re reading this week at Global Biodefense on topics like the dismissal of biodefense board members, Ebola case count update, neutralizing Syria’s chemical weapons and more…
Ticking viral bombs, left in boxes (NY Times)
Pakistanis use fake polio vaccination cards to travel overseas (Thomson Reuters)
Experts call for risk-benefit talks on lab-modified pathogens (CIDRAP)
The science of disarming Syria’s chemical weapons (Popular Mechanics)
Ebola outbreak update and current case count (WHO)
Identifying monoclonal antibodies that potently inhibit MERS-CoV (NCI)
Poor oversight catches up with high-security infectious agent labs (Scientific American)
There is no such thing as Ebola (Washington Post)
Cape Ray continues neutralizing Syrian chemical materials (Defense.gov)
The virus detective who discovered Ebola in 1976 (BBC News)
Want a grant? First review someone else’s proposal (Science Insider)
CDC director admits to pattern of unsafe practices (NY Times)
U.S. recovers hundreds of misplaced pathogen containers (NTI GSN)
Spread of chikungunya: A greater risk of spillover in Europe? (Eurosurveillance)
NSABB chief says board’s idling due to slow fed policy work (CIDRAP)
Sanofi’s 1.5B dengue vaccine shows Phase III promise, but questions linger (FierceBiotech)
20th CBRNE integrates into decisive action training (DVIDS)
Foot and mouth disease international field trials workshop (IIAD)
